首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

Pharmacogenetics and Genomics
ISSN：1744-6872

Pharmacogenetics and Genomics

PHARMACOGENET GENOM
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：约3.0个月
新锐分区：医学4区
年发文量：37
影响因子：1.7
JCR分区：Q3

基本信息

药物遗传学和基因组学致力于快速发表关于人类和动物对药物和其他化学品反应的遗传决定因素的研究论文、简要综述文章和简短通信。该期刊汇集了来自生物医学研究和科学的整个领域的论文，包括生物化学、生物信息学、临床药理学、临床药学、流行病学、遗传学、基因组学、分子生物学、药理学、药学科学和毒理学。在一个单一的封面下，该杂志提供了一个论坛，讨论宿主对外源化学物质反应的遗传学和基因组学的各个方面：从基因到临床。
1744-6872SCIE/Scopus收录
1.7
点击查看最新影响趋势>
1.6
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学4区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物
3区
GENETICS & HEREDITY 遗传学
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY
SCIE
Q4
138/177
学科：GENETICS & HEREDITY
SCIE
Q3
135/192
学科：PHARMACOLOGY & PHARMACY
SCIE
Q3
256/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY
SCIE
Q3
120/177
学科：GENETICS & HEREDITY
SCIE
Q3
129/192
学科：PHARMACOLOGY & PHARMACY
SCIE
Q3
236/353
134
37
点击查看年发文量趋势图>
3%0约3.0个月-医学-生物工程与应用微生物
5.9%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
94.59%7.14%-
CiteScore：2.60
SJR：0.553
SNIP：0.559
学科类别分区排名百分位
大类：Pharmacology, Toxicology and Pharmaceutics
小类：General Pharmacology, Toxicology and Pharmaceutics
Q2
35 / 77
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Genetics (clinical)
Q3
71 / 100
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Genetics
Q3
261 / 348
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Molecular Medicine
Q4
142 / 177
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Molecular Biology
Q4
329 / 410

期刊高被引文献

Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system.
来源期刊：Pharmacogenetics and genomicsDOI：10.1097/FPC.0000000000000383
CYP2D6 haplotypes with enhancer single-nucleotide polymorphism rs5758550 and rs16947 (*2 allele): implications for CYP2D6 genotyping panels
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000363
Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000362
Utility of human leukocyte antigen-B*58: 01 genotyping and patient outcomes
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000359
Gene expression changes in lymphoblastoid cell lines and primary B cells by dexamethasone
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000365
DNA methylation is associated with improvement in lung function on inhaled corticosteroids in pediatric asthmatics
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000366
Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy.
来源期刊：Pharmacogenetics and genomicsDOI：10.1097/FPC.0000000000000361
The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000374
Targeted ultra-deep sequencing of a South African Bantu-speaking cohort to comprehensively map and characterize common and novel variants in 65 pharmacologically-related genes
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000380
The effect of the CYP2D6 genotype on the maintenance dose of metoprolol in a chronic Dutch patient population.
来源期刊：Pharmacogenetics and genomicsDOI：10.1097/FPC.0000000000000381
Pharmacogeomic implications of population diversity in Latin America: TPMT and NUDT15 polymorphisms and thiopurine dosing
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000388
Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantation
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000360
International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000368
Impact of SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of phenylephrine and salbutamol by human SULT1A3 allozymes
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000371
Pharmacogenetic analysis of belimumab fails to identify robust genetic predictors of efficacy in lupus
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000378
N-acetyltransferase 2 acetylator genotype-dependent N-acetylation of 4-aminobiphenyl in cryopreserved human hepatocytes
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000394
Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000346
PharmGKB summary: sertraline pathway, pharmacokinetics
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000392
The role of phase I and II genetic polymorphisms, smoking, alcohol and cancer family history, in the risk of developing testicular cancer.
来源期刊：Pharmacogenetics and genomicsDOI：10.1097/FPC.0000000000000379
The relevance of the individual screening for genetic variants in predicting ovarian response.
来源期刊：Pharmacogenetics and genomicsDOI：10.1097/fpc.0000000000000386
Association between HNF4A mutations and bleeding complications in patients with stable international normalized ratio.
来源期刊：Pharmacogenetics and genomicsDOI：10.1097/FPC.0000000000000384
HLA-B*58:01 carrier status of Hmong in Minnesota: first in Hmong genotyping for prevalence of this biomarker of risk for severe cutaneous adverse reactions caused by allopurinol
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000391
Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han population
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000370
PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000376
Associations between TMEM196 polymorphisms and NSAID-exacerbated respiratory disease in asthma
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000367
Individuals with CYP2C8 and CYP2C9 reduced metabolism haplotypes self-adjusted ibuprofen dose in the Coriell Personalized Medicine Collaborative
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000364
N-acetyltransferase 2 enzyme genotype–phenotype discordances in both HIV-negative and HIV-positive Nigerians
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000373
A multiplex pharmacogenetics assay using the MinION nanopore sequencing device.
来源期刊：Pharmacogenetics and genomicsDOI：10.1097/fpc.0000000000000385
PharmGKB summary: very important pharmacogene information for CACNA1S
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000393
Fentanyl overdoses and pharmacogenetics
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000389
PharmGKB summary: Ondansetron and tropisetron pathways, pharmacokinetics and pharmacodynamics
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000369
Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer.
来源期刊：Pharmacogenetics and genomicsDOI：10.1097/FPC.0000000000000382
Enriched developmental biology molecular pathways impact on antipsychotics-induced weight gain
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000390
An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance)
来源期刊：Pharmacogenetics and GenomicsDOI：10.1097/FPC.0000000000000375

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

ACSMS HEALTH & FITNESS JOURNAL封面

ACSMS HEALTH & FITNESS JOURNAL

学科领域：医学
影响因子：1.8
中科院分区： 4区
ACTA BIOQUIMICA CLINICA LATINOAMERICANA封面

ACTA BIOQUIMICA CLINICA LATINOAMERICANA

学科领域：医学
影响因子：0.1
中科院分区： 4区
Acta Cardiologica Sinica封面

Acta Cardiologica Sinica

学科领域：医学
影响因子：1.8
中科院分区： 4区
Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca封面

Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca

学科领域：医学
影响因子：0.4
中科院分区： 4区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布
大类学科小类学科Top期刊综述期刊
医学4区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物
3区
GENETICS & HEREDITY 遗传学
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物
4区
GENETICS & HEREDITY 遗传学
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学3区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物
3区
GENETICS & HEREDITY 遗传学
3区
PHARMACOLOGY & PHARMACY 药学
3区
否
否